TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
AMGN

Amgen Inc

Healthcare · Drug Manufacturers - General

393.20$ +1.9% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios AMGN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
23.8 17.9 14.3 64.6 15.4 18.7 18.7 21.9 21.7 23.1 34.5 23.0
6.1 5.7 4.8 5.6 5.5 6.3 5.3 5.0 5.4 5.5 4.2 4.8
4.8 4.4 3.7 5.1 10.4 15.2 14.4 19.2 38.8 24.9 24.0 20.5
7.5 7.0 6.2 7.0 6.6 7.3 6.4 5.9 6.6 7.4 5.7 6.1
17.1 13.6 11.3 12.4 12.1 13.5 12.5 13.7 14.2 26.4 14.2 13.2
16.2 14.8 11.6 12.2 12.3 17.2 13.7 15.4 16.2 21.1 13.6 21.9
6.2% 6.8% 8.6% 8.2% 8.2% 5.8% 7.3% 6.5% 6.2% 4.7% 7.4% 4.6%
Margins
78.0% 80.5% 81.9% 82.2% 82.7% 81.4% 75.8% 75.2% 75.7% 70.0% 61.5% 70.8%
30.9% 39.1% 42.6% 43.6% 43.2% 41.4% 35.9% 29.4% 36.3% 28.0% 21.7% 29.1%
25.7% 32.0% 33.6% 8.7% 35.3% 33.6% 28.6% 22.7% 24.9% 23.8% 12.2% 21.0%
37.6% 38.9% 41.4% 46.0% 44.5% 36.5% 38.9% 32.3% 33.4% 26.1% 31.1% 22.0%
Returns
20.0% 24.7% 25.8% 7.8% 67.2% 81.1% 77.2% 88.0% 179.0% 107.8% 69.6% 89.1%
7.5% 9.7% 9.9% 2.5% 12.6% 13.1% 11.5% 9.6% 10.1% 6.9% 4.5% 8.5%
Balance Sheet & Debt
26,984 27,409 31,355 31,542 26,984 23,866 26,720 25,320 31,316 53,669 48,126 45,475
3.1 2.5 2.5 2.5 2.1 1.9 2.1 2.2 2.6 6.8 3.6 2.7
37.4% 39.2% 38.5% 31.6% 18.8% 16.2% 14.9% 11.0% 5.6% 6.4% 6.4% 9.6%
1.2 1.1 1.2 1.4 2.7 3.1 3.5 5.0 10.6 10.4 10.2 6.3
Per Share
6.70 9.06 10.24 2.69 12.62 12.88 12.31 10.28 12.11 12.49 7.56 14.23
26.06 28.28 30.49 31.09 35.71 38.36 43.09 45.34 48.66 52.40 61.78 67.79
33.48 36.66 39.62 34.34 18.80 15.88 15.95 11.69 6.77 11.58 10.86 15.97
9.81 11.00 12.62 14.30 15.88 14.01 16.76 14.63 16.24 13.68 19.21 14.94

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?